What's new? Log in Free sign up

Novo Nordisk (NVO) News and press releases

Company Profile

News

From Benzinga Pro

Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report

Large Cap, M&A, News, Health Care, Rumors, Movers, General

Danaher Corporation (NYSE: DHR) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT).

Novo Nordisk Q4 Highlights: Clocks 25% Increase In Sales On Strong Diabetes and Obesity Treatment, Expects 13% - 19% Revenue Growth

Biotech, Earnings, Large Cap, News, Health Care, General

Earnings Scheduled For February 1, 2023

Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.

Novo Nordisk Q4 EPS $0.81 Misses $0.85 Estimate, Sales $6.44B Miss $6.84B Estimate

Novo Nordisk (NYSE:NVO) reported quarterly earnings of $0.81 per share which missed the analyst consensus estimate of $0.85 by 4.71 percent. This is a 10.96 percent increase over earnings of $0.73 per share from the same

Here's How Much $100 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today

Earnings, News, Dividends

Novo Nordisk Earnings Preview

Mr. Beast Video Highlights Major Problem: Billions Will Need Eyecare According To Report

News, Health Care, General

Mr. Beast, a famous YouTuber known for pulling off outlandish stunts and business ventures, released a video in which he paid for cataract surgery for 1,000 patients.

$100 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today

Earnings, News, Dividends

Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide

Analyst Color, Biotech, Large Cap, News, Health Care, Price Target, Reiteration, Analyst Ratings, General

Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023.

Aeterna Zentaris Shelves Early-Stage Vaccine Programs, Including COVID-19

Biotech, News, Penny Stocks, Health Care, General

FUJIFILM Cellular Dynamics Announced Thursday, A License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies

FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSC), announced today that it has entered an agreement to grant global healthcare company Novo Nordisk A/S a non-exclusive right to use FUJIFILM Cellular Dynamics' iPSC platform for the development and commercialization of iPSC-derived cell therapies with a focus on addressing se

Jim Cramer Says Avoid This Stock: 'Too Expensive'

News, Small Cap, Markets, Media, Trading Ideas

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Blackline, Inc. (NASDAQ: BL) was an enterprise software company that was losing money.

Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says

Analyst Color, Biotech, M&A, News, Health Care, Price Target, Analyst Ratings, Movers, Trading Ideas, General

Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?

News, Short Ideas, Markets, Trading Ideas

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI above or near 70.

Why Jim Cramer Can't Recommend Investing In Carl Icahn's Company

News, Markets, Media, Trading Ideas

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Koninklijke Philips NV (NYSE: PHG) is "just not a well-enough run company." He added Danaher Corporation (NYSE: DHR) is the

Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13

Biotech, Cryptocurrency, Large Cap, News, Health Care, Legal, Top Stories, Markets, Tech, Media, General

Benzinga Sam Bankman-Fried Arrested In The Bahamas

After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023

Biotech, Large Cap, News, Health Care, Markets, General

Novo Nordisk A/S (NYSE: NVO) will roll out its obesity treatment, Wegovy (semaglutide), in Europe in 2023 to ensure it has enough supply.

Bloomberg Reported Earlier Novo Nordisk's Obesity Drug Wegovy's European Rollout Delayed After US Setbacks

https://www.bloomberg.com/news/articles/2022-12-13/novo-nordisk-delays-europe-obesity-drug-rollout-to-ensure-supply

Stocks That Hit 52-Week Lows On Thursday

During Thursday's session, 108 stocks hit new 52-week highs.

Novo Nordisk To Invest Over DKK5B To Add API Production Capacity To Danish Plant

Biotech, Large Cap, News, Health Care, General

Press releases

From Benzinga Pro

2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies

Melville, NY--News Direct--By Faith Ashmore, BenzingaBioRestorative Therapies Inc. (NASDAQ:BRTX) ("BioRestorative") may have had a successful year of novel drug development. The company is engaged in developing

Thinking about trading options or stock in Apple, Amazon, Sony, Walmart, or Novo Nordisk?

Opinion, Press Releases

NEW YORK, Jan. 19, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AMZN, SONY, WMT, and NVO.

Thinking about trading options or stock in Amazon, Coinbase, Novo Nordisk, First Solar, or Morgan Stanley?

Opinion, Press Releases

NEW YORK, Jan. 17, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMZN, COIN, NVO, FSLR, and MS.

Thinking about trading options or stock in Apple, Exxon Mobil, Novo Nordisk, Alibaba, or Bank of America?

Opinion, Press Releases

NEW YORK, Jan. 13, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, XOM, NVO, BABA, and BAC.

EXL Announces Appointment of Andreas Fibig to Board of Directors

News, Management, Press Releases

NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ:EXLS), a leading global data analytics and digital operations and solutions company, today announced that Andreas Fibig, a seasoned global

Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry

New York, New York--News Direct--By David Willey, BenzingaMedical device company Sharps Technology, Inc. (NASDAQ:STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market.

Thinking about trading options or stock in Apple, Novo Nordisk, Microsoft, Taiwan Semiconductor, or Walt Disney?

Opinion, Press Releases

NEW YORK, Dec. 30, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, NVO, MSFT, TSM, and DIS.

Medical Tech Company Concludes Successful Uplist to NYSE American

By David Willey, BenzingaSeattle, WA--News Direct--A U.S.-based medical device company recently completed its successful uplisting to the New York Stock Exchange (NYSE) American exchange. Know Labs Inc. (NYSEAMERICAN: